SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.from News-Economic Times https://ift.tt/2E3eKw3
Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine
SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.from News-Economic Times https://ift.tt/2E3eKw3
Related Posts:
Army 'holding' clash area, PLA blocking 8km Pangong stretch- Releasing Rana on bail will strain ties with India: US attorney
- China may enact Hong Kong security law at end of June
- World now feeling need for yoga more than ever, it's helping COVID patients defeat disease: Modi
- SC ruling on Jagannath Rath Yatra: Artisans shed tears
0 Comments:
Post a Comment